FDA approves Lupin’s generic Dovonex Scalp Solution

Press enter to search
Close search
Open Menu

FDA approves Lupin’s generic Dovonex Scalp Solution

01/02/2018

The Food and Drug Administration has approved Lupin’s generic of Leo Pharmaceutical Products’ Dovonex Scalp Solution (calcipotriene topical solution, 0.005%). The product is indicated for the topical treatment of moderately severe psoriasis on the scalp.


According to IQVIA data, the product had U.S. sales of roughly $5.9 million for the 12 months ended October 2017.